Graham Capital Management, L.P. Akero Therapeutics, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 10,897 shares of AKRO stock, worth $293,783. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,897Holding current value
$293,783% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
168Shares Held
72.7MCall Options Held
178KPut Options Held
164K-
Janus Henderson Group PLC London, X06.88MShares$185 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$151 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$146 Million2.13% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$141 Million3.88% of portfolio
-
Wellington Management Group LLP Boston, MA5.11MShares$138 Million0.02% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.25B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...